Author
Listed:
- Koji M. Nishiguchi
(Harvard Medical School, Massachusetts Eye and Ear Infirmary)
- Michael A. Sandberg
(Harvard Medical School, Massachusetts Eye and Ear Infirmary)
- Aart C. Kooijman
(University Hospital Groningen)
- Kirill A. Martemyanov
(Harvard Medical School, Massachusetts Eye and Ear Infirmary)
- Jan W. R. Pott
(University Hospital Groningen)
- Stephanie A. Hagstrom
(Harvard Medical School, Massachusetts Eye and Ear Infirmary
Cleveland Clinic Foundation)
- Vadim Y. Arshavsky
(Harvard Medical School, Massachusetts Eye and Ear Infirmary)
- Eliot L. Berson
(Harvard Medical School, Massachusetts Eye and Ear Infirmary)
- Thaddeus P. Dryja
(Harvard Medical School, Massachusetts Eye and Ear Infirmary)
Abstract
The RGS proteins are GTPase activating proteins that accelerate the deactivation of G proteins in a variety of signalling pathways in eukaryotes1,2,3,4,5,6. RGS9 deactivates the G proteins (transducins) in the rod and cone phototransduction cascades7,8. It is anchored to photoreceptor membranes by the transmembrane protein R9AP (RGS9 anchor protein), which enhances RGS9 activity up to 70-fold9,10,11. If RGS9 is absent or unable to interact with R9AP, there is a substantial delay in the recovery from light responses in mice4,12,13. We identified five unrelated patients with recessive mutations in the genes encoding either RGS9 or R9AP who reported difficulty adapting to sudden changes in luminance levels mediated by cones. Standard visual acuity was normal to moderately subnormal, but the ability to see moving objects, especially with low-contrast, was severely reduced despite full visual fields; we have termed this condition bradyopsia. To our knowledge, these patients represent the first identified humans with a phenotype associated with reduced RGS activity in any organ.
Suggested Citation
Koji M. Nishiguchi & Michael A. Sandberg & Aart C. Kooijman & Kirill A. Martemyanov & Jan W. R. Pott & Stephanie A. Hagstrom & Vadim Y. Arshavsky & Eliot L. Berson & Thaddeus P. Dryja, 2004.
"Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation,"
Nature, Nature, vol. 427(6969), pages 75-78, January.
Handle:
RePEc:nat:nature:v:427:y:2004:i:6969:d:10.1038_nature02170
DOI: 10.1038/nature02170
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:427:y:2004:i:6969:d:10.1038_nature02170. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.